gptkbp:instanceOf
|
gptkb:chemical_compound
|
gptkbp:antidote
|
gptkb:physostigmine
gptkb:pilocarpine
|
gptkbp:boilingPoint
|
decomposes
|
gptkbp:CASNumber
|
6581-06-2
|
gptkbp:category
|
gptkb:quinuclidine
chemical weapon
anticholinergic deliriant
benzilate ester
incapacitating agent
|
gptkbp:chemicalFormula
|
C10H10N2O
|
gptkbp:countryOfOperation
|
gptkb:Soviet_Union
gptkb:United_States
|
gptkbp:developedBy
|
gptkb:Edgewood_Arsenal
|
gptkbp:discoveredBy
|
1951
|
gptkbp:effect
|
confusion
delirium
blurred vision
tachycardia
hallucinations
dry mouth
|
gptkbp:hasInChIKey
|
QXJYQKZQGZKJFI-UHFFFAOYSA-N
|
gptkbp:hasSMILES
|
O=C(OC1CC2CCC1C2)C3=CC=CC=C3N
|
https://www.w3.org/2000/01/rdf-schema#label
|
B.Z.
|
gptkbp:IUPACName
|
gptkb:3-Quinuclidinyl_benzilate
|
gptkbp:legalStatus
|
gptkb:Schedule_2_(USA)
|
gptkbp:mechanismOfAction
|
anticholinergic
|
gptkbp:meltingPoint
|
165–166 °C
|
gptkbp:molecularWeight
|
284.35 g/mol
|
gptkbp:notableFor
|
studied as a non-lethal weapon
use in chemical warfare
|
gptkbp:otherName
|
gptkb:QNB
gptkb:Agent_BZ
BZ
|
gptkbp:PubChem_CID
|
10241
9826
CHEMBL2106067
|
gptkbp:riskFactor
|
toxic
deliriant
|
gptkbp:routeOfExposure
|
inhalation
ingestion
skin contact
|
gptkbp:solubility
|
slightly soluble in water
|
gptkbp:UNII
|
Q7V2JZ4B8V
|
gptkbp:usedAs
|
incapacitating agent
|
gptkbp:usedBy
|
gptkb:military
|
gptkbp:usedIn
|
gptkb:Operation_Whitecoat
gptkb:Operation_DORK
|
gptkbp:bfsParent
|
gptkb:Axel_Springer_Gesellschaft_mit_beschränkter_Haftung_(before_SE_conversion)
|
gptkbp:bfsLayer
|
6
|